Concepedia

Oriol Arqués

OA

Statistics

Publications

13

Citations

1.4K

H-Index

13

Active since

2011

Affiliations

Vall d'Hebron Institute of Oncology(Current)

CIBBIM-Nanomedicine

Universitat Autònoma de Barcelona

Vall d'Hebron Hospital Universitari

Vall d'Hebron Institut de Recerca

Oriol Arqués is an author at Vall d'Hebron Institute of Oncology specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2011–2024

13

Publications

13

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Stephan P. Tenbaum, Paloma Ordóñez‐Morán, Isabel Puig et al. · Nature Medicine · 2012 · 400 citations · Full text

, , +17

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

Oriol Arqués, Irene Chicote, Isabel Puig et al. · Clinical Cancer Research · 2015 · 177 citations

, , +15

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

Elena Garralda, Marie-Ève Beaulieu, Víctor Moreno et al. · Nature Medicine · 2024 · 174 citations · Full text

, , +13

TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

Isabel Puig, Stephan P. Tenbaum, Irene Chicote et al. · Journal of Clinical Investigation · 2018 · 109 citations · Full text

, , +17

DualMET andERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Alex Martínez‐Martí, Enriqueta Felip, Judit Matito et al. · Annals of Oncology · 2017 · 87 citations · Full text

, , +17

1–5 of 13